Emerald Advisers »

Dianthus Therapeutics shares owned by Emerald Advisers

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $24M 248k 97.48

More positions owned by Emerald Advisers

Travere Therapeutics (TVTX)
Cardinal Infrastructure Grou (CDNL)
Mercury Computer Systems (MRCY)
Aar (AIR)
VSE Corporation (VSEC)
Kulicke and Soffa Industries (KLIC)
Argan (AGX)
CECO Environmental (CECO)
Corcept Therapeutics Incorporated (CORT)
Livanova Plc Ord (LIVN)
Semtech Corporation (SMTC)
InterDigital (IDCC)
ESCO Technologies (ESE)
Axcelis Technologies (ACLS)
PDF Solutions (PDFS)

View all positions for Emerald Advisers

Top funds holding Dianthus Therapeutics

FMR
BlackRock
Wellington Management Company
Fairmount Funds Management
Vanguard Capital Management
Avidity Partners Management
Octagon Capital Advisors
TCG Crossover Management
State Street Corporation
Fred Alger Management
Geode Capital Management
VR Adviser
T. Rowe Price Associates
UBS Group
Deerfield Management Company

View all funds holding Dianthus Therapeutics